Paul Ryan

Dr. Paul Ryan

Queen Mary University of London
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PRPaul Ryan
Paul Ryan
NSNital Sumaria
Nital Sumaria
CHChristopher J. Holland
Christopher J. Holland
CBClaire M. Bradford
Claire M. Bradford
NINatalia Izotova
Natalia Izotova
DPDaniel J. Pennington
Daniel J. Pennington
Significance: A type of human white blood cell, known as the Vδ2 (+) T cell, has shown promise in immunotherapies against a range of tumors. However, in recent clinical trials patient responses and clinical outcomes have been variable and unpredictable. To address this, we here reveal a significant variability in Vδ2 (+) T-cell functional potential between individuals in the general population, which develops shortly after birth, is stable over time, and is manifested by differential mechanistic capacities to kill tumor targets. These results support personalized clinical approaches to identify patients with “Vδ2 profiles” that are compatible with killing of their particular tumor and suggest that tailored Vδ2-profile–specific activation protocols may maximize the chances of future treatment success.

13 March 2017 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
MHM S Hasan
M S Hasan
PRPaul Ryan
Paul Ryan
LBL A Bergmeier
L A Bergmeier
FFF Fortune
F Fortune
Summary: Behçet's disease (BD) is an autoinflammatory, chronic relapsing/remitting disease of unknown aetiology with both innate and acquired immune cells implicated in disease pathogenesis. Peripheral blood natural killer (NK) cells and their CD56Dim/CD56Bright subsets were surface phenotyped using CD27 and CD16 surface markers in 60 BD patients compared to 60 healthy controls (HCs). Functional potential was assessed by production of interferon (IFN)-γ, granzyme B, perforin and the expression of degranulation marker CD107a. The effects of disease activity (BDActive versus BDQuiet) and BD medication on NK cells were also investigated. Peripheral blood NK cells (P < 0·0001) and their constituent CD56Dim (P < 0·0001) and CD56Bright (P = 0·0015) subsets were depleted significantly in BD patients compared to HCs, and especially in those with active disease (BDActive) (P < 0·0001). BD patients taking azathioprine also had significantly depleted NK cells compared to HCs (P < 0·0001). A stepwise multivariate linear regression model confirmed BD activity and azathioprine therapy as significant independent predictor variables of peripheral blood NK percentage (P < 0·001). In general, CD56Dim cells produced more perforin (P < 0·0001) and granzyme B (P < 0·01) expressed higher CD16 levels (P < 0·0001) compared to CD56Bright cells, confirming their increased cytotoxic potential with overall higher NK cell CD107a expression in BD compared to HCs (P < 0·01). Interestingly, IFN-γ production and CD27 expression were not significantly different between CD56Dim/CD56Bright subsets. In conclusion, both BD activity and azathioprine therapy have significant independent depletive effects on the peripheral blood NK cell compartment.

21 December 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRSimon C.F. Rawlinson
Simon C.F. Rawlinson
IMIan J. McKay
Ian J. McKay
MGMandeep Ghuman
Mandeep Ghuman
CWClaudia Wellmann
Claudia Wellmann
PRPaul Ryan
Paul Ryan
VKVirginia J. Kingsmill
Virginia J. Kingsmill
The incidence of limb bone fracture and subsequent morbidity and mortality due to excessive bone loss is increasing in the progressively ageing populations of both men and women. In contrast to bone loss in the weight-bearing limb, bone mass in the protective skull vault is maintained. One explanation for this could be anatomically diverse bone matrix characteristics generated by heterogeneous osteoblast populations. We have tested the hypothesis that adult bones demonstrate site-specific characteristics, and report differences at the organ, cell and transcriptome levels. Limb bones contain greater amounts of polysulphated glycosaminoglycan stained with Alcian Blue and have significantly higher osteocyte densities than skull bone. Site-specific patterns persist in cultured adult bone-derived cells both phenotypically (proliferation rate, response to estrogen and cell volumes), and at the level of specific gene expression (collagen triple helix repeat containing 1, reelin and ras-like and estrogen-regulated growth inhibitor). Based on genome-wide mRNA expression and cluster analysis, we demonstrate that bones and cultured adult bone-derived cells segregate according to site of derivation. We also find the differential expression of genes associated with embryological development (Skull: Zic, Dlx, Irx, Twist1 and Cart1; Limb: Hox, Shox2, and Tbx genes) in both adult bones and isolated adult bone-derived cells. Together, these site-specific differences support the view that, analogous to different muscle types (cardiac, smooth and skeletal), skull and limb bones represent separate classes of bone. We assign these differences, not to mode of primary ossification, but to the embryological cell lineage; the basis and implications of this division are discussed.

1 December 2020 in Cells
Verified
Journal Article
Open access
PDF file
MCMatthew L. Clohosey
Matthew L. Clohosey
BMBrendan Mann
Brendan Mann
PRPaul Ryan
Paul Ryan
TATatiyana Apanasovich
Tatiyana Apanasovich
SMSanjay Maggirwar
Sanjay Maggirwar
NSNatalia Soriano-Sarabia
Natalia Soriano-Sarabia
Crosstalk between innate and adaptive pathways is a critical component to developing an effective, lasting immune response. Among natural effector cells, innate-like γδ T cells promote immunity by facilitating communication between the two compartments and exerting cytotoxic effector functions. Dysregulation of γδ T cell populations is a byproduct of primary Humanimmunodeficiency virus (HIV) infection. This is most pronounced in the depletion and loss of function within cells expressing a Vγ9Vδ2 TCR (Vδ2 cells). Whether or not prolonged viral suppression mediated by antiretroviral therapy (ART) can reverse these effects has yet to be determined. In this study, we present evidence of similar Vδ2 cell functional responses within a cohort of people living with HIV (PLWH) that has been stably suppressed for >1 year and uninfected donors. Through the use of aminobisphosphonate drugs, we were able to generate a comprehensive comparison between ex vivo and expanded Vδ2 cells within each group. Both groups had largely similar compositions of memory and effector phenotypes, post-expansion TCR repertoire diversity, and cytotoxic capabilities. Our findings support the notion that ART promotes the recovery of Vδ2 polyfunctionality and provides insight for strategies aiming to reconstitute the full immune response after infection with HIV.

1 March 2013 in Journal of Dentistry
Verified
Journal Article
Closed access
VKVirginia J. Kingsmill
Virginia J. Kingsmill
IMIan J. McKay
Ian J. McKay
PRPaul Ryan
Paul Ryan
MOMatthew R. Ogden
Matthew R. Ogden
SRSimon C.F. Rawlinson
Simon C.F. Rawlinson

2 December 2012 in Dental Update
Verified
Journal Article
Closed access
PRPaul Ryan
Paul Ryan
KPKim M Piper
Kim M Piper
FHFrancis J Hughes
Francis J Hughes
SKSathya Kannan
Sathya Kannan
ATArishiya Thapasum
Arishiya Thapasum
MSMonica C Solomon
Monica C Solomon
Langerhans cell histiocytosis (LCH) is a rare clonal neoplastic disorder of unknown aetiology which can present with a diverse range of clinical presentations. It encompasses a diverse number of idiopathic conditions which can involve multiple body systems and is characterized by bone marrow-derived Langerhans cell proliferation. The disease can affect multiple body systems and lesions can be solitary or widespread. We present a case of a multifocal eosinophilic granuloma (LCH) in a young adult female with clinical signs and symptoms similar to aggressive periodontitis. Clinical Relevance: Langerhans cell histiocytosis is a rare disease which can have a similar clinical presentation to aggressive periodontitis.